الخلفيةأبلغ الصندوق العالمي لمكافحة الإيدز والسل والملاريا مؤخرًا البلدان بخفض كبير في التمويل المخصص لدورة المنح السابعة (2025–2027)، وأصدر « مظاريف إرشادية » يوم الاثنين 30 يونيو 2025، وهي ميزانيات مؤقتة تُظهر المبالغ المحتملة التي قدRead More
Context: The Middle East and North Africa (MENA) region continues to face major public health challenges related to HIV/AIDS. Key populations, including young people, men who have sex with men, sex workers, andRead More
***(Activists Development Program in MENA Region) Contexte : La région du Moyen-Orient et de l’Afrique du Nord (MENA) continue de faire face à des défis majeurs en matière de santé publique liés au VIH/sida.Read More
ABOUT ITPC-MENA ITPC-MENA is a regional non-governmental organization operating in the MiddleEast and North Africa region bringing together a network of community activistsunited by our vision of a longer, healthier, more productive life forRead More
**Titre : Consultant pour Co-Animer un Atelier de Formation Régionale et Rédiger le Rapport Global Contexte : La région du Moyen-Orient et de l’Afrique du Nord (MENA) fait face à des défis majeursRead More
*Focus only on (Egypt, Lebanon, Morocco, Jordan, and Tunisia). ITPC-MENA is delighted to announce the launch of our HIV and Leadership training program designed for young activists. This program is crafted to enhanceRead More
Source : ITPC EECA Against the backdrop of a recent press release from Gilead announcing the signing of a voluntary license for the new drug lenacapavir, ViiV Healthcare has announced an increase inRead More
Press Statement – 4 October 2024 Today’s announcement by Gilead that six generic manufacturers have been awarded voluntary licenses for the production of lenacapavir—a groundbreaking, twice-yearly injectable for HIV prevention and potential treatment—raises significantRead More
Source : ITPC Global ITPC Global’s reaction to Gilead’s voluntary licence on lenacapravir: Gilead’s announcement of their voluntary license for lenacapavir—a groundbreaking, long-acting HIV prevention method—highlights why we cannot rely on pharmaceutical companiesRead More
ITPC-MENA is pleased to announce the publication of its latest study, titled « Data Exclusivity under Moroccan Law: Implications for Access to Generic Medicines. » This comprehensive report examines the impact of Morocco’s data exclusivity provisions,Read More
